logo
Select company
Select metric
$ -10.55MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
25
Sector
60
Industry
77
History
38
$ 2.65Close
$ 1.55 - $ 2.72 52-Week Range
Ticker Information

Ticker

ENTX

Company Name

ENTERA BIO LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTERA BIO LTD - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 37K$ -10.59M$ -10.55M
3/31/2025$ 41K$ -10.08M$ -10.04M
12/31/2024$ 46K$ -9.53M$ -9.48M
9/30/2024$ 48K$ -9.18M$ -9.13M
6/30/2024$ 51K$ -8.51M$ -8.46M
3/31/2024$ 55K$ -8.69M$ -8.63M
12/31/2023$ 56K$ -8.86M$ -8.8M
9/30/2023$ 59K$ -9.95M$ -9.89M
6/30/2023$ 61K$ -10.47M$ -10.41M
3/31/2023$ 62K$ -11.33M$ -11.27M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTERA BIO LTD's latest trailing twelve months (TTM) EBITDA stands at $ -10.97M.
  • Over the past 5 years, ENTERA BIO LTD's average EBITDA has been $ -10.61M.
  • The median EBITDA for ENTERA BIO LTD during this period was $ -9.96M
  • ENTERA BIO LTD reached its highest EBITDA over the past 5 years at $ -4.73M.
  • The lowest EBITDA recorded by ENTERA BIO LTD in the same timeframe $ -18.96M

ENTERA BIO LTD's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
INO : INOVIO PHARMACEUTICALS INC $ -84.73MMNOV : MEDICINOVA INC $ -11.61MAPLT : APPLIED THERAPEUTICS INC $ -67.34MSER : SERINA THERAPEUTICS INC $ -12.18MRPTX : REPARE THERAPEUTICS INC $ -103.08MINMB : INMUNE BIO INC $ -55.51MABP : ABPRO HOLDINGS INC $ -10.56MHCWB : HCW BIOLOGICS INC $ -8.92MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -8.95MEXOZ : EXOZYMES INC $ -7.68M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ENTERA BIO LTD is calculated as follows: EBIT [ $ -11.17M ] + DepAmor [ $ 205K ]
(=) EBITDA [ $ -10.97M ]

ENTX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -18.96M

Minimum

Sep 30, 2021

$ -4.73M

Maximum

Jun 30, 2022

$ -10.61M

Average

$ -9.96M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M